The Take Solutions stock has not had a great start to 2018, but a recent brokerage note suggests investors are upbeat about the prospects of the company capturing a bigger share of life sciences drug discovery spending.
In an interview to CNBC-TV18, Srinivasan HR, MD of Take Solutions said that life sciences research and development (R&D) services is a large market of about USD 35-40 billion.
He further said that for the first nine months of the year, the company has grown their life science business at 30 percent in terms of dollar and 25 percent, in terms of rupees.
“We have a healthy order book and life science business alone stands at $151 million and we expect this growth trend to continue over the next several quarters”, he added.